Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Mirati Therapeutics

Mirati Therapeutics reported $4.2M in Interest Income for its fiscal quarter ending in March of 2022.

Interest Income Change
Agios Pharmaceuticals AGIO:US USD 8.09M 1.6M
Alnylam Pharmaceuticals ALNY:US USD 18.65M 4.58M
BioCryst Pharmaceuticals BCRX:US USD 3.38M 674K
Bluebird Bio BLUE:US USD 2.82M 2.46M
Eli Lilly LLY:US USD 34.2M 8.7M
Exelixis EXEL:US USD 19.5M 2.51M
Moderna Inc MRNA:US USD 109M 22M
Nektar Therapeutics NKTR:US USD 4.03M 908K
Pfizer PFE:US USD 177M 40M
Puma Biotechnology PBYI:US USD 537K 18K
Sarepta Therapeutics SRPT:US USD 9.28M 150K
Ultragenyx Pharmaceutical RARE:US USD 6.29M 92K